¹Ìµð¾î

ÇØ´ç ÄÁÆÛ·±½º´Â Á¾·áµÇ¾ú½À´Ï´Ù.
Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_


Ç¥½ÃÇϱâ:

Engineering
°øÇÐ ½ºÆ®¸²
  • Display of Biologics
    ¹ÙÀÌ¿À·ÎÁ÷½ºÀÇ µð½ºÇ÷¹ÀÌ
  • Engineering Antibodies
    Ç×ü °øÇÐ
  • Machine Learning for Protein Engineering
    ´Ü¹éÁú ¿£Áö´Ï¾î¸µ¿ë ±â°èÇнÀ
Oncology
Á¾¾ç ½ºÆ®¸²
  • Antibodies for Cancer Therapy
    ¾ÏÄ¡·á¿ë Ç×ü
  • Emerging Targets for Oncology & Beyond
    Á¾¾ç ÀÌ¿Ü ½Å±Ô Ÿ±ê
  • Driving Clinical Success in Antibody-Drug Conjugates
    Ç×ü¾à¹°Á¢ÇÕü(ADC)ÀÇ ÀÓ»óÀû ¼º°øÀÇ ÃßÁø
Bispecific Antibodies
´ÙÁ߯¯À̼º ½ºÆ®¸²
Immunotherpary
¸é¿ªÄ¡·á ½ºÆ®¸²
  • Advances in Immunotherapy
    ¸é¿ªÄ¡·áÀÇ Áøº¸
  • Engineering Cell Therapies
    ¼¼Æ÷Ä¡·á °øÇÐ
  • Next-Generation Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á
Expression
¹ßÇö ½ºÆ®¸²
  • Difficult-to-Express Proteins
    ¹ßÇöÀÌ ¾î·Á¿î ´Ü¹éÁú
  • Optimizing Protein Expression
    ´Ü¹éÁú ¹ßÇöÀÇ ÃÖÀûÈ­
  • Maximizing Protein Production Workflows
    ´Ü¹éÁú »ý»ê ¿öÅ©Ç÷οìÀÇ ÃÖ´ëÈ­
Analytical
ºÐ¼®¹ý ½ºÆ®¸²
  • ML and Digital Integration in Biotherapeutic Analytics
    ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¼®¿¡¼­ ML°ú µðÁöÅÐ ÅëÇÕ
  • Biophysical Methods
    »ý¹°¹°¸®ÇÐÀû ¹æ¹ý
  • Characterization for Novel Biotherapeutics
    ½Å±Ô ¹ÙÀÌ¿ÀÀǾàǰÀÇ Æ¯¼º Æò°¡
Immunogenicity
¸é¿ª¿ø¼º ½ºÆ®¸²
Emerging Modalities
½Å±Ô Ä¡·á ½ºÆ®¸²
  • Biologics for Immunology Indications
    ÀûÀÀ ¸é¿ª¿ë ¹ÙÀÌ¿À·ÎÁ÷½º
  • Radiopharmaceutical Therapies
    ¹æ»ç¼º ÀǾàǰ Ä¡·á
  • Next-Generation Immunotherapies
    Â÷¼¼´ë ¸é¿ªÄ¡·á
Machine Learning Stream
±â°èÇнÀ ½ºÆ®¸²
  • ML and Digital Integration in Biotherapeutic Analytics
    ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¼®¿¡¼­ ML°ú µðÁöÅÐ ÅëÇÕ
  • Predicting Immunogenicity with AI/ML Tools
    AI/ML Åø¿¡ ÀÇÇÑ ¸é¿ª¿ø¼º ¿¹Ãø
  • Machine Learning for Protein Engineering
    ´Ü¹éÁú ¿£Áö´Ï¾î¸µ¿ë ±â°èÇнÀ

Premier Sponsors

FairJourneyBiologics GenScript-CRO Integral-Molecular_NEW  LONZAOmniAbUnchainedLabs
Catalog Download
Catalog